Rein Therapeutics to be Acquired by 03 Life Sciences
Ticker: RNTX · Form: 8-K · Filed: Jun 24, 2025 · CIK: 1420565
| Field | Detail |
|---|---|
| Company | Rein Therapeutics, Inc. (RNTX) |
| Form Type | 8-K |
| Filed Date | Jun 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, merger, corporate-action
TL;DR
Rein Therapeutics is getting bought by 03 Life Sciences, deal expected to close Q3 2025.
AI Summary
Rein Therapeutics, Inc. announced on June 24, 2025, that it has entered into a definitive agreement to be acquired by 03 Life Sciences. The transaction is expected to close in the third quarter of 2025, subject to customary closing conditions. This acquisition marks a significant development for Rein Therapeutics, which was formerly known as Aileron Therapeutics, Inc.
Why It Matters
The acquisition of Rein Therapeutics by 03 Life Sciences could lead to new developments in pharmaceutical research and potentially impact the availability of future treatments.
Risk Assessment
Risk Level: medium — The acquisition is subject to customary closing conditions, which introduces a level of uncertainty until the deal is finalized.
Key Players & Entities
- Rein Therapeutics, Inc. (company) — Registrant
- 03 Life Sciences (company) — Acquiring entity
- Aileron Therapeutics, Inc. (company) — Former name of Rein Therapeutics
- June 24, 2025 (date) — Date of report and earliest event
- Third quarter of 2025 (date) — Expected closing period for the acquisition
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing reports on the definitive agreement for Rein Therapeutics, Inc. to be acquired by 03 Life Sciences.
Who is acquiring Rein Therapeutics, Inc.?
Rein Therapeutics, Inc. is being acquired by 03 Life Sciences.
When is the acquisition expected to close?
The acquisition is expected to close in the third quarter of 2025.
What was Rein Therapeutics, Inc. formerly known as?
Rein Therapeutics, Inc. was formerly known as Aileron Therapeutics, Inc.
Are there any specific financial details mentioned regarding the acquisition?
No specific dollar amounts or financial terms of the acquisition are detailed in this filing.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 regarding Rein Therapeutics, Inc. (RNTX).